SAN FRANCISCO and NEW YORK and MELBOURNE, Australia, April 8, 2019 /PRNewswire/ -- Synchron, Inc. today announced the initiation of the...
FARMINGTON HILLS, Mich. and IOWA CITY, Iowa, April 8, 2019 /PRNewswire/ -- The University of Iowa Carver College of Medicine has...
REDMOND, Wash., April 8, 2019 /PRNewswire/ -- On April 13 thousands will join the "Megathon" event from home and in public...
First results of a major three-year project to analyze airborne grass pollen LONDON, UK / ACCESSWIRE / April 8, 2019...
LOS ANGELES, CA / ACCESSWIRE / April 8, 2019 / Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company...
TORONTO, ON / ACCESSWIRE / April 8, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) provides update on the closing...
VANCOUVER, BC / ACCESSWIRE / April 8, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (OTC...
Companies to Combine Cutting-Edge Delivery Technologies, Coupled with Advanced Computational Capabilities and Robotics for Development of Innovative Cannabinoid-Based Biopharmaceuticals MALVERN,...
Mr. Goldman also joins newly formed Board special committee established to evaluate strategic options LIVINGSTON, NJ / ACCESSWIRE / April...
Efficacy data from the REIMAGINE Phase IIa basket trial's Borderline Personality Disorder (BPD) cohort Vafidemstat is an active compound in...
- Study to generate comprehensive biomarker data by breast cancer sub-type to support phase 3 registration program - Interim data...